Nanoparticle-based gene editing could expand treatment options for cystic fibrosis

Researchers have demonstrated that lipid nanoparticles can package and deliver an entire therapeutic gene along with gene-editing machinery - a combination of large, complex components that non-viral carriers haven't been able to handle before.